{
    "1646076885678292993": {
        "author_id": "194037150",
        "created_at": "2023-04-12T09:04:46.000Z",
        "edit_history_tweet_ids": [
            "1646076885678292993"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 23,
                    "normalized_text": "Biosystems",
                    "probability": 0.456,
                    "start": 14,
                    "type": "Organization"
                },
                {
                    "end": 40,
                    "normalized_text": "Novo Nordisk",
                    "probability": 0.5981,
                    "start": 29,
                    "type": "Organization"
                },
                {
                    "end": 113,
                    "normalized_text": "diabetes",
                    "probability": 0.6844,
                    "start": 106,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 6,
                    "start": 0,
                    "tag": "PRESS"
                }
            ]
        },
        "id": "1646076885678292993",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 7898,
            "like_count": 43,
            "quote_count": 2,
            "reply_count": 4,
            "retweet_count": 11
        },
        "text": "#PRESS Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity"
    }
}